Zobrazeno 1 - 10 of 781 pro vyhledávání: '"Betzi, S."'
1
Akademický článek
ChemoDOTS: a web server to design chemistry-driven focused libraries.
Autor: Hoffer L; CRCM, CNRS, Inserm, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille 13273, France., Charifi-Hoareau G; CRCM, CNRS, Inserm, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille 13273, France., Barelier S; CRCM, CNRS, Inserm, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille 13273, France., Betzi S; CRCM, CNRS, Inserm, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille 13273, France., Miller T; CRCM, CNRS, Inserm, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille 13273, France., Morelli X; CRCM, CNRS, Inserm, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille 13273, France., Roche P; CRCM, CNRS, Inserm, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille 13273, France.
Publikováno v: Nucleic acids research [Nucleic Acids Res] 2024 Jul 05; Vol. 52 (W1), pp. W461-W468.
Zobrazit plný text záznamu
2
Akademický článek
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress.
Autor: Calbert ML; Department of Biochemistry and Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.; Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania., Chandramouly G; Department of Biochemistry and Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Adams CM; Department of Pharmacology, Physiology, and Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Saez-Ayala M; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Kent T; Department of Biochemistry and Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Tyagi M; Department of Biochemistry and Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Ayyadevara VSSA; Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania., Wang Y; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Krais JJ; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Gordon J; Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, Pennsylvania., Atkins J; Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania., Toma MM; Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania., Betzi S; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Boghossian AS; Broad Institute of MIT and Harvard, Cambridge Massachusetts., Rees MG; Broad Institute of MIT and Harvard, Cambridge Massachusetts., Ronan MM; Broad Institute of MIT and Harvard, Cambridge Massachusetts., Roth JA; Broad Institute of MIT and Harvard, Cambridge Massachusetts., Goldman AR; The Wistar Institute, Philadelphia, Pennsylvania., Gorman N; The Wistar Institute, Philadelphia, Pennsylvania., Mitra R; Division of Biostatistics, Department of Pharmacology, Physiology, and Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Childers WE; Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, Pennsylvania., Graña X; Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania., Skorski T; Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania., Johnson N; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Hurtz C; Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania., Morelli X; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Eischen CM; Department of Pharmacology, Physiology, and Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Pomerantz RT; Department of Biochemistry and Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2024 May 02; Vol. 23 (5), pp. 683-699.
Zobrazit plný text záznamu
3
Akademický článek
PDZome-wide and structural characterization of the PDZ-binding motif of VANGL2.
Autor: Montserrat-Gomez M; Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe labellisée Ligue 'Cell polarity, cell signaling and cancer', Marseille, France., Gogl G; Universite de Strasbourg, INSERM, CNRS, IGBMC, Department of Integrated Structural Biology, Illkirch, France., Carrasco K; Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Integrative Structural & Chemical Biology, Marseille, France., Betzi S; Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Integrative Structural & Chemical Biology, Marseille, France., Durbesson F; Aix Marseille Université, CNRS, Architecture et fonction des macromolécules biologiques (AFMB), Marseille, France., Cousido-Siah A; Universite de Strasbourg, INSERM, CNRS, IGBMC, Department of Integrated Structural Biology, Illkirch, France., Kostmann C; Universite de Strasbourg, INSERM, CNRS, IGBMC, Department of Integrated Structural Biology, Illkirch, France., Essig DJ; Center for Biopharmaceuticals, Jagtvej 162, 2100 Copenhagen, Denmark; Global Research Technologies, Novo Nordisk Research Park, 2760 Maaloev, Denmark., Strømgaard K; Center for Biopharmaceuticals, Jagtvej 162, 2100 Copenhagen, Denmark., Østergaard S; Global Research Technologies, Novo Nordisk Research Park, 2760 Maaloev, Denmark., Morelli X; Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Integrative Structural & Chemical Biology, Marseille, France., Trave G; Universite de Strasbourg, INSERM, CNRS, IGBMC, Department of Integrated Structural Biology, Illkirch, France., Vincentelli R; Aix Marseille Université, CNRS, Architecture et fonction des macromolécules biologiques (AFMB), Marseille, France. Electronic address: renaud.vincentelli@univ-amu.fr., Bailly E; Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe labellisée Ligue 'Cell polarity, cell signaling and cancer', Marseille, France. Electronic address: eric.bailly@inserm.fr., Borg JP; Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe labellisée Ligue 'Cell polarity, cell signaling and cancer', Marseille, France; Institut Universitaire de France (IUF), France. Electronic address: jean-paul.borg@inserm.fr.
Publikováno v: Biochimica et biophysica acta. Proteins and proteomics [Biochim Biophys Acta Proteins Proteom] 2024 May 01; Vol. 1872 (3), pp. 140989. Date of Electronic Publication: 2023 Dec 23.
Zobrazit plný text záznamu
4
Inhibiting Type VI Secretion System Activity with a Biomimetic Peptide Designed To Target the Baseplate Wedge Complex
Autor: Cherrak, Y., Filella-Merce, I., Schmidt, V., Byrne, D., Sgoluppi, V., Chaiaheloudjou, R., Betzi, S., Morelli, X., Nilges, M., Pellarin, R., Durand, E.
Publikováno v: mBio
mBio, 2021, 12 (4), ⟨10.1128/mBio.01348-21⟩
mBio, 2021, 12 (4), ⟨10.1128/mbio.01348-21⟩
mBio, 2021, 12 (4), pp.e0134821. ⟨10.1128/mBio.01348-21⟩
mBio, American Society for Microbiology, 2021, 12 (4), ⟨10.1128/mbio.01348-21⟩
mBio, Vol 12, Iss 4 (2021)
International audience; Human health is threatened by bacterial infections that are increasingly resistant to multiple drugs. A recently emerged strategy consists of disarming pathogenic bacteria by targeting and blocking their virulence factors. The
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::69e621a61ecafcc9623245b2e10e8518
https://hal-amu.archives-ouvertes.fr/hal-03366988
Zobrazit plný text záznamu
5
Akademický článek
From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia.
Autor: Saez-Ayala M; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France. magali.saez-ayala@inserm.fr., Hoffer L; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France.; Drug Discovery Program, Ontario Institute for Cancer Research (OICR), Toronto, ON, Canada., Abel S; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Ben Yaala K; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Sicard B; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Andrieu GP; Institut Necker Enfants Malades (INEM), INSERM, Hôpital Necker Enfants-Malades, Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France., Latiri M; Institut Necker Enfants Malades (INEM), INSERM, Hôpital Necker Enfants-Malades, Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France., Davison EK; Department of Chemistry, Faculty of Science, University of British Columbia, Vancouver, BC, Canada.; Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada., Ciufolini MA; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France.; Department of Chemistry, Faculty of Science, University of British Columbia, Vancouver, BC, Canada., Brémond P; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Rebuffet E; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Roche P; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Derviaux C; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Voisset E; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Montersino C; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Castellano R; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Collette Y; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Asnafi V; Institut Necker Enfants Malades (INEM), INSERM, Hôpital Necker Enfants-Malades, Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France., Betzi S; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France., Dubreuil P; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France. patrice.dubreuil@inserm.fr., Combes S; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France. sebastien.combes@univ-amu.fr., Morelli X; Centre de Recherche en Cancérologie de Marseille (CRCM), CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille, France. xavier.morelli@inserm.fr.
Publikováno v: Nature communications [Nat Commun] 2023 May 29; Vol. 14 (1), pp. 3079. Date of Electronic Publication: 2023 May 29.
Zobrazit plný text záznamu
6
Akademický článek
Discovery of a PDZ Domain Inhibitor Targeting the Syndecan/Syntenin Protein-Protein Interaction: A Semi-Automated "Hit Identification-to-Optimization" Approach.
Autor: Hoffer L; Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Inserm 1068, CNRS 7258, Institut Paoli Calmettes, Marseille 13009, France., Garcia M; Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Inserm 1068, CNRS 7258, Institut Paoli Calmettes, Marseille 13009, France., Leblanc R; Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Inserm 1068, CNRS 7258, Institut Paoli Calmettes, Marseille 13009, France., Feracci M; Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Inserm 1068, CNRS 7258, Institut Paoli Calmettes, Marseille 13009, France., Betzi S; Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Inserm 1068, CNRS 7258, Institut Paoli Calmettes, Marseille 13009, France., Ben Yaala K; Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Inserm 1068, CNRS 7258, Institut Paoli Calmettes, Marseille 13009, France., Daulat AM; Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Inserm 1068, CNRS 7258, Institut Paoli Calmettes, Marseille 13009, France., Zimmermann P; Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Inserm 1068, CNRS 7258, Institut Paoli Calmettes, Marseille 13009, France., Roche P; Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Inserm 1068, CNRS 7258, Institut Paoli Calmettes, Marseille 13009, France., Barral K; Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Inserm 1068, CNRS 7258, Institut Paoli Calmettes, Marseille 13009, France., Morelli X; Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Inserm 1068, CNRS 7258, Institut Paoli Calmettes, Marseille 13009, France.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2023 Apr 13; Vol. 66 (7), pp. 4633-4658. Date of Electronic Publication: 2023 Mar 20.
Zobrazit plný text záznamu
8
Akademický článek
Antimicrobial and cytotoxic effects of marine sponge extracts Agelas clathrodes , Desmapsamma anchorata and Verongula rigida from a Caribbean Island.
Autor: Piron J; Groupe de Recherche BIOSPHERES, Université des Antilles, Campus de Schoelcher, Martinique, France., Betzi S; Centre de Recherche en Cancérologie de Marseille (CRCM) - Aix-Marseille Université, Inserm, CNRS, Institut Paoli Calmettes, Marseille, France., Pastour J; Groupe de Recherche BIOSPHERES, Université des Antilles, Campus de Schoelcher, Martinique, France., Restouin A; Centre de Recherche en Cancérologie de Marseille (CRCM) - Aix-Marseille Université, Inserm, CNRS, Institut Paoli Calmettes, Marseille, France., Castellano R; Centre de Recherche en Cancérologie de Marseille (CRCM) - Aix-Marseille Université, Inserm, CNRS, Institut Paoli Calmettes, Marseille, France., Collette Y; Centre de Recherche en Cancérologie de Marseille (CRCM) - Aix-Marseille Université, Inserm, CNRS, Institut Paoli Calmettes, Marseille, France., Tysklind N; INRAE - UMR 0745 ECOFOG, Campus Agronomique CEDEX, Kourou, Guyane, France., Smith-Ravin J; Groupe de Recherche BIOSPHERES, Université des Antilles, Campus de Schoelcher, Martinique, France.; Association AREBio Immeuble Bellevue, Fort de France, Martinique, France., Priam F; Groupe de Recherche BIOSPHERES, Université des Antilles, Campus de Schoelcher, Martinique, France.; Association AREBio Immeuble Bellevue, Fort de France, Martinique, France.
Publikováno v: PeerJ [PeerJ] 2022 Sep 23; Vol. 10, pp. e13955. Date of Electronic Publication: 2022 Sep 23 (Print Publication: 2022).
Zobrazit plný text záznamu
9
Akademický článek
Discovery of Small-Molecule Inhibitors of the PTK7/β-Catenin Interaction Targeting the Wnt Signaling Pathway in Colorectal Cancer.
Autor: Ganier L; Aix Marseille Univ., CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe labellisée Ligue 'Cell Polarity, Cell Signaling and Cancer', 27 Blvd Lei Roure CS30059, 13273 Marseille Cedex 9, France.; Aix Marseille Univ., CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Team 'Integrative Structural and Chemical Biology', 27 Blvd Lei Roure CS30059, 13273 Marseille Cedex 9, France., Betzi S; Aix Marseille Univ., CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Team 'Integrative Structural and Chemical Biology', 27 Blvd Lei Roure CS30059, 13273 Marseille Cedex 9, France.; Aix Marseille Univ., CNRS, INSERM, Institut Paoli-Calmettes, CRCM, 'HiTS/IPCdd─High Throughput Screening Platform', 27 Blvd Lei Roure CS30059, 13273 Marseille Cedex 9, France., Derviaux C; Aix Marseille Univ., CNRS, INSERM, Institut Paoli-Calmettes, CRCM, 'HiTS/IPCdd─High Throughput Screening Platform', 27 Blvd Lei Roure CS30059, 13273 Marseille Cedex 9, France., Roche P; Aix Marseille Univ., CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Team 'Integrative Structural and Chemical Biology', 27 Blvd Lei Roure CS30059, 13273 Marseille Cedex 9, France.; Aix Marseille Univ., CNRS, INSERM, Institut Paoli-Calmettes, CRCM, 'HiTS/IPCdd─High Throughput Screening Platform', 27 Blvd Lei Roure CS30059, 13273 Marseille Cedex 9, France., Dessaux C; Aix Marseille Univ., CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe labellisée Ligue 'Cell Polarity, Cell Signaling and Cancer', 27 Blvd Lei Roure CS30059, 13273 Marseille Cedex 9, France., Muller C; Aix Marseille Univ., CNRS, INSERM, Institut Paoli-Calmettes, CRCM, 'HiTS/IPCdd─High Throughput Screening Platform', 27 Blvd Lei Roure CS30059, 13273 Marseille Cedex 9, France., Hoffer L; Aix Marseille Univ., CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Team 'Integrative Structural and Chemical Biology', 27 Blvd Lei Roure CS30059, 13273 Marseille Cedex 9, France., Morelli X; Aix Marseille Univ., CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Team 'Integrative Structural and Chemical Biology', 27 Blvd Lei Roure CS30059, 13273 Marseille Cedex 9, France.; Aix Marseille Univ., CNRS, INSERM, Institut Paoli-Calmettes, CRCM, 'HiTS/IPCdd─High Throughput Screening Platform', 27 Blvd Lei Roure CS30059, 13273 Marseille Cedex 9, France., Borg JP; Aix Marseille Univ., CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe labellisée Ligue 'Cell Polarity, Cell Signaling and Cancer', 27 Blvd Lei Roure CS30059, 13273 Marseille Cedex 9, France.; Institut Universitaire de France, 17 Rue de France, 69100 Villeurbanne, France.
Publikováno v: ACS chemical biology [ACS Chem Biol] 2022 May 20; Vol. 17 (5), pp. 1061-1072. Date of Electronic Publication: 2022 Apr 28.
Zobrazit plný text záznamu
10
Akademický článek
CRCM5484: A BET-BDII Selective Compound with Differential Anti-leukemic Drug Modulation.
Autor: Carrasco K; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France., Montersino C; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France.; Institut Paoli-Calmettes, Plateforms HiTS & TrGET, Marseille 13009, France., Derviaux C; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France.; Institut Paoli-Calmettes, Plateforms HiTS & TrGET, Marseille 13009, France., Saez-Ayala M; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France., Hoffer L; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France., Restouin A; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France.; Institut Paoli-Calmettes, Plateforms HiTS & TrGET, Marseille 13009, France., Castellano R; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France.; Institut Paoli-Calmettes, Plateforms HiTS & TrGET, Marseille 13009, France., Casassa J; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France., Roche P; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France., Pasquier E; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France., Combes S; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France., Morelli X; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France.; Institut Paoli-Calmettes, Plateforms HiTS & TrGET, Marseille 13009, France., Collette Y; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France.; Institut Paoli-Calmettes, Plateforms HiTS & TrGET, Marseille 13009, France., Betzi S; CNRS, INSERM, Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM, Marseille 13009, France.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2022 Apr 14; Vol. 65 (7), pp. 5660-5674. Date of Electronic Publication: 2022 Mar 29.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje